Though, TCE has been found to inhibit mitogen-activated protein kinase (MAPK) and matrix metalloproteinase 9(MMP-9) pathway and decrease invasion and migration abilities of tumor cells (Lee et al., 2019). The gene discussed is WNK2; the disease is neoplasm.